Replenishing our defensive microbes

BioEssays

Volumn 35, Issue 9, 2013, Pages 810-817

  Ursell, Luke K ^a   Treuren, William Van ^a   Metcalf, Jessica L ^a   Pirrung, Meg ^b   Gewirtz, Andrew ^c   Knight, Rob ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Antibiotics; Ecology; Gut microbiota; Human microbiome; Hygiene hypothesis; Pathogens

Indexed keywords

ANTIBIOTIC AGENT; CHLORTETRACYCLINE; PENICILLIN DERIVATIVE; RNA 16S; VANCOMYCIN;

ACIDOBACTERIUM; ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; BETAPROTEOBACTERIA; BIFIDOBACTERIUM; CESAREAN SECTION; CITROBACTER RODENTIUM; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DOMESTIC ANIMAL; ECOLOGY; ENTERITIS; ENTEROCOCCUS; ENVIRONMENTAL EXPOSURE; FECES ANALYSIS; FIRMICUTES; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION; INFECTION RESISTANCE; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LEISHMANIA MAJOR; LIFESTYLE; LIVESTOCK; MALAWI; MEXICO; MICROBIAL COMMUNITY; MICROBIOME; MICROFLORA; MICROORGANISM; NONHUMAN; OBESITY; PARASITE; POPULATION RESEARCH; RECURRENT DISEASE; RURAL AREA; SPIROPLASMA; STAPHYLOCOCCUS EPIDERMIDIS; SYMBIONT; TREPONEMA; UNITED STATES; URBAN AREA; VAGINAL DELIVERY; VENEZUELA; VIRUS INFECTION; WEIGHT GAIN;

ANTIBIOTICS; ECOLOGY; GUT MICROBIOTA; HUMAN MICROBIOME; HYGIENE HYPOTHESIS; PATHOGENS;

ANIMALS; DISEASE; ECOSYSTEM; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; METAGENOME; MICROBIOTA; PROBIOTICS;

EID: 84881614224     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201300018     Document Type: Article

References (64)

1. Blaser MJ, Falkow S. 2009. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7: 887-94.
2. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-14.
3. Qin J, Li R, Raes J, Arumugam M, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
4. Jaenike J, Unckless R, Cockburn SN, Boelio LM, et al. 2010. Adaptation via symbiosis: recent spread of a Drosophila defensive symbiont. Science 329: 212-5.
5. Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, et al. 2011. Altering host resistance to infections through microbial transplantation. PLoS ONE 6: e26988.
6. Lawley TD, Clare S, Walker AW, Stares MD, et al. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8: e1002995.
7. Dillon RJ, Vennard CT, Buckling A, Charnley AK. 2005. Diversity of locust gut bacteria protects against pathogen invasion. Ecol Lett 8: 1291-8.
8. Havstad S, Wegienka G, Zoratti EM, Lynch SV, et al. 2011. Effect of prenatal indoor pet exposure on the trajectory of total IgE levels in early childhood. J Allergy Clin Immunol 128: 880-5.e4.
9. Scanlan PD, Marchesi JR. 2008. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2: 1183-93.
10. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-70.
11. Walter J, Ley RE. 2010. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 65: 411-29.
12. Lee YK, Mazmanian SK. 2010. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330: 1768-73.
13. Littman DR, Pamer EG. 2011. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 10: 311-23.
14. Josefowicz SZ, Niec RE, Kim HY, Treuting P, et al. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-9.
15. Izcue A, Coombes JL, Powrie F. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212: 256-71.
16. Geuking MB, Cahenzli J, Lawson MA, Ng DC, et al. 2011. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34: 794-806.
17. Round JL, Mazmanian SK. 2010. Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107: 12204-9.
18. Atarashi K, Tanoue T, Shima T, Imaoka A, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-41.
19. Rolig AS, Cech C, Ahler E, Carter JE, et al. 2013. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect Immun 81: 1382-9.
20. Lamouse-Smith ES, Tzeng A, Starnbach MN. 2011. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS ONE 6: e27662.
21. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, et al. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 108: 5354-9.
22. Johnson PT, Preston DL, Hoverman JT, Richgels KL. 2013. Biodiversity decreases disease through predictable changes in host community competence. Nature 494: 230-3.
23. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457: 480-4.
24. Comito D, Romano C. 2012. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int J Inflam 2012: 687143.
25. Ivanov II, Atarashi K, Manel N, Brodie EL, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-98.
26. Ivanov II, Littman DR. 2011. Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol 14: 106-14.
27. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, et al. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337: 1115-9.
28. Tito RY, Knights D, Metcalf J, Obregon-Tito AJ, et al. 2012. Insights from characterizing extinct human gut microbiomes. PLoS ONE 7: e51146.
29. Tito RY, Macmil S, Wiley G, Najar F, et al. 2008. Phylotyping and functional analysis of two ancient human microbiomes. PLoS ONE 3: e3703.
30. Yatsunenko T, Rey FE, Manary MJ, Trehan I, et al. 2012. Human gut microbiome viewed across age and geography. Nature 486: 222-7.
31. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
32. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108: 4554-61.
33. Koenig JE, Spor A, Scalfone N, Fricker AD, et al. 2011. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108: 4578-85.
34. Ubeda C, Taur Y, Jenq RR, Equinda MJ, et al. 2010. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120: 4332-41.
35. Sommer MO, Dantas G, Church GM. 2009. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325: 1128-31.
36. Looft T, Johnson TA, Allen HK, Bayles DO, et al. 2012. In-feed antibiotic effects on the swine intestinal microbiome. Proc Natl Acad Sci USA 109: 1691-6.
37. Cho I, Yamanishi S, Cox L, Methe BA, et al. 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621-6.
38. Flint HJ. 2012. Microbiology: antibiotics and adiposity. Nature 488: 601-2.
39. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, et al. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-31.
40. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, et al. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-5.
41. Trasande L, Blustein J, Liu M, Corwin E, et al. 2013. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 37: 16-23.
42. Adlerberth I, Wold AE. 2009. Establishment of the gut microbiota in Western infants. Acta Paediatr 98: 229-38.
43. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107: 11971-5.
44. Huurre A, Kalliomaki M, Rautava S, Rinne M, et al. 2008. Mode of delivery - effects on gut microbiota and humoral immunity. Neonatology 93: 236-40.
45. Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, et al. 2009. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 39: 518-26.
46. Song SJ, Lauber C, Costello EK, Lozupone CA, et al. 2013. Cohabiting family members share microbiota with one another and with their dogs. eLife 2: e00458.
47. Mountzouris KC, McCartney AL, Gibson GR. 2002. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr 87: 405-20.
48. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, et al. 2011. Moving pictures of the human microbiome. Genome Biol 12: R50.
49. Costello EK, Lauber CL, Hamady M, Fierer N, et al. 2009. Bacterial community variation in human body habitats across space and time. Science 326: 1694-7.
50. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3: 213-23.
51. Wu GD, Chen J, Hoffmann C, Bittinger K, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-8.
52. Candela M, Biagi E, Maccaferri S, Turroni S, et al. 2012. Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol 20: 385-91.
53. Goodman AL, Kallstrom G, Faith JJ, Reyes A, et al. 2011. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 108: 6252-7.
54. Manichanh C, Reeder J, Gibert P, Varela E, et al. 2010. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 20: 1411-9.
55. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, et al. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-75.
56. Preidis GA, Versalovic J. 2009. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136: 2015-31.
57. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, et al. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra.
58. Diaz Heijtz R, Wang S, Anuar F, Qian Y, et al. 2011. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108: 3047-52.
59. Neu J. 2007. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65: 282-5.
60. Borody TJ, Warren EF, Leis SM, Surace R, et al. 2004. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38: 475-83.
61. Seksik P, Sokol H, Lepage P, Vasquez N, et al. 2006. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 24: 11-8.
62. Johnson S, Kent SA, O'Leary KJ, Merrigan MM, et al. 2001. Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med 135: 434-8.
63. Kato N, Ou CY, Kato H, Bartley SL, et al. 1991. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 29: 33-7.
64. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, et al. 1994. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271: 1913-8.